Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer-Reference-Cited by-同舟云学术

Reduced cardiotoxicity and comparable efficacy in a phase IIItrial of pegylated liposomal doxorubicin HCl(CAELYX™/Doxil®) versus conventional doxorubicin forfirst-line treatment of metastatic breast cancer

Published:2004-03 Issue:3 Volume:15 Page:440-449
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

O’Brien M.E.R.,Wigler N.,Inbar M.,Rosso R.,Grischke E.,Santoro A.,Catane R.,Kieback D.G.,Tomczak P.,Ackland S.P.,Orlandi F.,Mellars L.,Alland L.,Tendler C.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/15/3/440/558158/mdh097.pdf

Reference25 articles.

1. Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists’ Collaborative Group;Lancet,1998

2. Combination chemotherapy versus single-agent therapy as first- and second-line treatment in metastatic breast cancer: a prospective randomized trial;Joensuu;J Clin Oncol,1998

3. Combination versus sequential single agent chemotherapy in advanced breast cancer: associations with metastatic sites and long-term survival. The Western Cancer Study Group and The Southeastern Cancer Study Group;Chlebowski;Br J Cancer,1989

4. New treatments for breast cancer;Smith;Semin Oncol,1996

5. Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes;Symon;Cancer,1999

Cited by 1427 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro assessment of nanomedicines' propensity to cause palmar-plantar erythrodysesthesia: A Doxil vs. doxorubicin case study;Nanomedicine: Nanotechnology, Biology and Medicine;2024-11

2. Evaluation of D-Mannoheptulose and Doxorubicin as Potential Therapeutic Agents for Breast Cancer by Targeting Glycolysis and Inducing Apoptosis;Indian Journal of Clinical Biochemistry;2024-09-11

3. The supramolecular processing of liposomal doxorubicin hinders its therapeutic efficacy in cells;Molecular Therapy: Oncology;2024-09

4. Simultaneous therapeutic and diagnostic applications of magnetic PLGA nanoparticles loaded with doxorubicin in rabbit;Drug Delivery and Translational Research;2024-08-31

5. Rationale and design of RESILIENCE: A prospective randomized clinical trial evaluating remote ischaemic conditioning for the prevention of anthracycline cardiotoxicity;European Journal of Heart Failure;2024-08-30